Cognitive reserve, presynaptic proteins and dementia in the elderly

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Honer, W G ^a   Barr, A M ^a   Sawada, K ^a,b   Thornton, A E ^c   Morris, M C ^d   Leurgans, S E ^e,f   Schneider, J A ^e,f   Bennett, D A ^e,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KOCHI UNIVERSITY   (Japan)

^c SIMON FRASER UNIVERSITY   (Canada)

^d RUSH MEDICAL COLLEGE   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f RUSH UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; cognitive reserve; complexin; dementia; SNARE protein

Indexed keywords

COMPLEXIN I; COMPLEXIN II; NERVE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; SYNAPTOBREVIN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; COGNITION; COGNITIVE RESERVE; CONTROLLED STUDY; DEMENTIA; FEMALE; GERIATRIC PATIENT; HUMAN; HUMAN TISSUE; MALE; PROSPECTIVE STUDY; PROTEIN PROTEIN INTERACTION; ATROPHY; BRAIN; BRAIN CORTEX; LONGITUDINAL STUDY; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN DOMAIN; REFERENCE VALUE; RISK ASSESSMENT; SYNAPSE;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATROPHY; BRAIN; CEREBRAL CORTEX; CEREBRAL INFARCTION; COGNITIVE RESERVE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MEMBRANE PROTEINS; MILD COGNITIVE IMPAIRMENT; NERVE TISSUE PROTEINS; PROTEIN INTERACTION DOMAINS AND MOTIFS; QA-SNARE PROTEINS; R-SNARE PROTEINS; REFERENCE VALUES; RISK ASSESSMENT; SYNAPSES; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 84861302752     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.38     Document Type: Article

References (40)

1. Stern Y. Cognitive reserve. Neuropsychologia 2009; a 47: 2015-2028.
2. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; a 298: 789-791.
3. Washbourne P, Thompson PM, Carta M, Costa ET, Mathews JR, Lopez-Benditó a G et al. Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat Neurosci 2002; a 5: 19-26.
4. Glynn D, Bortnick RA, Morton AJ. Complexin II is essential for normal neurological function in mice. Hum Mol Genet 2003; a 12: 2431-2448.
5. Drew CJ, Kyd RJ, Morton AJ. Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal. Hum Mol Genet 2007; a 16: 2288-2305.
6. Schoch S, Deak F, Konigstorfer A, Mozhayeva M, Sara Y, Südhof TC et al. SNARE function analyzed in synaptobrevin/VAMP knock-out mice. Science 2001; a 294: 1117-1122.
7. Fujiwara T, Mishima T, Kofuji T, Chiba T, Tanaka K, Yamamoto A et al. Analysis of knock-out mice to determine the role of HPC-1/syntaxin 1A in expressing synaptic plasticity. J Neurosci 2006; a 26: 5767-5776.
8. Schmitt U, Tanimoto N, Seeliger M, Schaeffel F, Leube RE. Detection of behavioral alterations and learning deficits in mice lacking synaptophysin. Neuroscience 2009; a 162: 234-243.
9. Webster MJ, Elashoff M, Weickert CS. Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int J Devel Neurosci 2011; a 29: 225-236.
10. Troncoso JC, Zonderman AB, Resnick SM, Crain B, Pletnikova O, O0Brien RJ. Effect of infarcts on dementia in the Baltimore longitudinal study of aging. Ann Neurol 2008; a 64: 168-176.
11. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007; a 62: 406-413.
12. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D et al. AD lesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 2005; a 57: 98-103.
13. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; a 30: 572-580.
14. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 1995; a 16: 285-304.
15. Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007; a 68: 1501-1508.
16. Minger SL, Honer WG, Esiri MM, McDonald B, Keene J, Nicoll JA et al. Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer's disease. J Neuropathol Exp Neurol 2001; a 60: 929-936.
17. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008; a 14: 837-842.
18. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008; a 321: 1686-1689.
19. Petrie EC, Cross DJ, Galasko D, Schellenberg GD, Raskind MA, Peskind ER et al. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol 2009; a 66: 632-637.
20. Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. New Engl J Med 1996; a 334: 752-758.
21. Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA 2004; a 101: 284-289.
22. Barakauskas VE, Beasley CL, Barr AM, Ypsilanti AR, Li HY, Thornton AE et al. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology 2010; a 35: 1226-1238.
23. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. New Engl J Med 2009; a 360: 2302-2309.
24. Bennett DA, Schneider JA, Buchman AS, De Leon CM, Bienias JL, Wilson RS. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005; a 25: 163-175.
25. Bennett DA, Schneider JA, Tang Y, Arnold SA, Wilson RS. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: A longitudinal cohort study. Lancet Neurol 2006; a 5: 406-412.
26. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; a 66: 1837-1844.
27. Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol 2007; a 62: 59-66.
28. Bennett DA, Wilson RS, Schneider JA, Evans DA, Aggarwal NT, Arnold SE et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003; a 60: 246-252.
29. Cohen J. A power primer. Psychol Bull 1992; a 112: 155-159.
30. Levin JR. Overcoming feelings of powerlessness in 'aging' researchers: A primer on statistical power in analysis of variance designs. Psychol Aging 1997; a 12: 84-106.
31. Beasley CL, Honer WG, von Bergmann K, Falkai P, Lutjohann D, Bayer TA. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord 2005; a 7: 449-455.
32. Tannenberg RK, Scott HL, Tannenberg AE, Dodd PR. Selective loss of synaptic proteins in Alzheimer's disease: Evidence for an increased severity with APOE varepsilon4. Neurochem Int 2006; a 49: 631-639.
33. Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 2005; a 62: 263-272.
34. Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 2010; a 67: 879-888.
35. Barr AM, Hofmann CE, Phillips AG, Weinberg J, Honer WG. Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex. Alcohol Clin Exp Res 2005; a 29: 1915-1920.
36. Jeans AF, Oliver PL, Johnson R, Capogna M, Vikman J, Molná ar Z et al. A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl Acad Sci USA 2007; a 104: 2431-2436.
37. Yang Y, Shin JY, Oh JM, Jung CH, Hwang Y, Kim S et al. Dissection of SNARE-driven membrane fusion and neuroexocytosis by wedging small hydrophobic molecules into the SNARE zipper. Proc Natl Acad Sci USA 2010; a 107: 22145-22150.
38. Schneider JA, Arvanitakis Z, Bnag W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; a 6: 2197-2204.
39. Smith MZ, Nagy Z, Barnetson L, King EM-F, Esiri MM. Coexisting pathologies in the brain: Influence of vascular disease and Parkinson's disease on Alzheimer's pathology in the hippocampus. Acta Neuropathol 2000; a 100: 87-94.
40. Cracchiolo JR, Mori T, Nazian SJ, Tan J, Potter H, Arendash GW. Enhanced cognitive activity-over and above social or physical activity-is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 2007; a 88: 277-294.